マイクロ流体デバイスの市場規模、シェア、成長分析、製品別、素材別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

マイクロ流体デバイスの世界市場規模は2023年に244億8,000万米ドルとなり、2024年の276億1,000万米ドルから2032年には723億8,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは12.8%で成長する見通しです。

世界のマイクロ流体デバイス市場は著しい成長を遂げており、今後さらに加速すると予測されています。これらの革新的なツールは、ヘルスケア、製薬、バイオテクノロジー、研究所など、さまざまな分野で不可欠です。これらのツールは、迅速で正確な結果を提供する、コンパクトでポータブル、かつコスト効率の高い診断ソリューションの構築を容易にします。マイクロ流体デバイスは、サンプル調製、分析、検出などの機能を一つのプラットフォームに統合することで、特に資源の限られた遠隔地での使用に適しています。ヘルスケアの分野では、検査工程の小型化、サンプルや試薬の必要量の最小化を通じて、医療診断学に大きな変革をもたらしました。その結果、マイクロ流体ベースのアッセイは検査速度、効率、費用対効果を高め、分子診断、免疫アッセイ、細胞分析、ゲノミクスでの使用を促進し、市場需要を大幅に増加させています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 原材料の分析

マイクロ流体デバイス市場規模：製品別

• 市場概要
• マイクロ流体ベースのデバイス
• マイクロ流体コンポーネント
  • マイクロ流体チップ
  • 流量・圧力センサー
  • 流量・圧力コントローラ
  • マイクロ流体バルブ
  • マイクロポンプ
  • マイクロニードル
  • その他のコンポーネント

マイクロ流体デバイス市場規模：素材別

• 市場概要
• ガラス
• シリコン
• ポリマー
• その他

マイクロ流体デバイス市場規模：用途別

• 市場概要
• 体外診断
  • 臨床診断
  • ポイントオブケア検査
  • 獣医診断
• 医薬品およびライフサイエンスの調査と製造
  • ラボ分析
  • マイクロディスペンシング
  • マイクロ反応
• 治療薬
  • ドラッグデリバリー
  • ウェアラブルデバイス

マイクロ流体デバイス市場規模：エンドユーザー別

• 市場概要
• 製薬・バイオテクノロジー企業
• 調査機関
• 診断センター
• ヘルスケア施設等

マイクロ流体デバイス市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Bio-Rad Laboratories（USA）
• Illumina（USA）
• PerkinElmer（USA）
• Abbott Laboratories（USA）
• Thermo Fisher Scientific（USA）
• bioMerieux（France）
• Danaher Corporation（USA）
• Agilent Technologies（USA）
• Sphere Fluidics（UK）
• Standard BioTools（formerly Fluidigm Corporation）（USA）
• BD（Becton, Dickinson and Company）（USA）
• IDEX Corporation（USA）
• SMC Corporation（Japan）
• Parker Hannifin Corporation（USA）
• Fortive Corporation（USA）
• Aignep S.p.A（Italy）
• Lonza Group（Switzerland）
• Emulate（USA）
• Dolomite Bio（UK）

結論と推奨事項

Global Microfluidic Devices Market size was valued at USD 24.48 billion in 2023 and is poised to grow from USD 27.61 billion in 2024 to USD 72.38 billion by 2032, growing at a CAGR of 12.8% during the forecast period (2025-2032).

The global microfluidic devices market is experiencing remarkable growth, projected to accelerate further. These innovative tools are essential across various sectors, including healthcare, pharmaceuticals, biotechnology, and research labs. They facilitate the creation of compact, portable, and cost-effective diagnostic solutions that provide rapid, accurate results. By integrating functions like sample preparation, analysis, and detection onto a single platform, microfluidic devices are particularly suited for resource-limited and remote settings. The healthcare sector has been a key adopter, transforming medical diagnostics through the miniaturization of laboratory processes and minimizing sample and reagent requirements. Consequently, microfluidic-based assays enhance testing speed, efficiency, and cost-effectiveness, driving their use in molecular diagnostics, immunoassays, cell analysis, and genomics, thereby significantly increasing market demand.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microfluidic Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Microfluidic Devices Market Segmental Analysis

Global Microfluidic Devices Market is segmented by Product, Material, Application, End User and region. Based on Product, the market is segmented into Microfluidic-based Devices and Microfluidic Components. Based on Material, the market is segmented into Glass, Silicon, Polymer and Others. Based on Application, the market is segmented into In-vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics. Based on End User, the market is segmented into Pharmaceutical and Biotechnology Companies, Research Institutes, Diagnostic Centers and Healthcare Facilities and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Microfluidic Devices Market

The Global Microfluidic Devices market is experiencing significant growth driven by the rising demand for compact and portable solutions across multiple industries such as healthcare, pharmaceuticals, and biotechnology. These devices are ideally positioned to address this need due to their small footprint, which allows for reduced sample consumption and the integration of various functions into a single device. Their capability to execute intricate laboratory procedures on a miniature scale, coupled with the convenience of portability and the ability for on-site analysis, has led to increased adoption. This trend is propelling the expansion of the microfluidic devices market as it caters to evolving application demands.

Restraints in the Global Microfluidic Devices Market

The global microfluidic devices market faces certain restraints primarily due to limited awareness and slow adoption in various industries beyond healthcare and diagnostics. Sectors such as agriculture, environmental monitoring, and food testing, which stand to benefit significantly from microfluidic technologies, tend to adopt these innovations at a slower pace. This lag is often attributed to inadequate awareness, insufficient infrastructure, and a strong reliance on traditional methods. To foster market growth, it is essential to enhance awareness and educate potential end-users about the diverse advantages and applications of microfluidic devices across these underserved industries.

Market Trends of the Global Microfluidic Devices Market

The Global Microfluidic Devices market is witnessing a robust trend toward the increased adoption of point-of-care testing (POCT) applications, driven by the growing demand for rapid and accurate diagnostic solutions. Microfluidic technology facilitates immediate testing at or near the patient, enabling healthcare professionals to make swift decisions based on real-time data. The ability to manage small sample volumes, coupled with their portable and user-friendly design, positions these devices favorably across diverse healthcare environments such as hospitals, clinics, and even home care settings. This trend is particularly significant in emergency and critical care scenarios, underscoring the vital role of microfluidics in enhancing patient outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Raw Material Analysis

Global Microfluidic Devices Market Size by Product & CAGR (2025-2032)

• Market Overview
• Microfluidic-based Devices
• Microfluidic Components
  • Microfluidic Chips
  • Flow & Pressure Sensors
  • Flow & Pressure Controllers
  • Microfluidic Valves
  • Micropumps
  • Microneedles
  • Other Components

Global Microfluidic Devices Market Size by Material & CAGR (2025-2032)

• Market Overview
• Glass
• Silicon
• Polymer
• Others

Global Microfluidic Devices Market Size by Application & CAGR (2025-2032)

• Market Overview
• In-vitro Diagnostics
  • Clinical Diagnostics
  • Point-of-care Testing
  • Veterinary Diagnostics
• Pharmaceutical & Life Science Research and Manufacturing
  • Lab Analytics
  • Microdispensing
  • Microreaction
• Therapeutics
  • Drug Delivery
  • Wearables Devices

Global Microfluidic Devices Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical and Biotechnology Companies
• Research Institutes
• Diagnostic Centers
• Healthcare Facilities and Others

Global Microfluidic Devices Market Size & CAGR (2025-2032)

• North America (Product, Material, Application, End User)
  • US
  • Canada
• Europe (Product, Material, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Material, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Material, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Material, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Bio-Rad Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sphere Fluidics (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Standard BioTools (formerly Fluidigm Corporation) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IDEX Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SMC Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parker Hannifin Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fortive Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aignep S.p.A (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emulate (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dolomite Bio (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations